Search Results
Suggested Topics within your search.
Suggested Topics within your search.
- COVID-19 12
- COVID-19 (Disease) 12
- Coronavirus infections 12
- SARS-CoV-2 12
- Treatment
- therapeutic use
- drug therapy 10
- Antiviral Agents 8
- Antiviral agents 8
- Chemotherapy 8
- Development 8
- Betacoronavirus 6
- Clinical trials 6
- administration & dosage 6
- immunology 6
- Antibodies, Monoclonal 4
- Clinical Trials as Topic 4
- Coronavirus Infections 4
- Drug Development 4
- Drug Discovery 4
- Drug development 4
- Immunological aspects 4
- Interferon 4
- Interferon-beta 4
- Monoclonal antibodies 4
- Nebulizers and Vaporizers 4
- Pneumonia, Viral 4
- Research 4
- Therapeutic use 4
- Treatment Outcome 4
-
1
SARS-COV-2 human monoclonal antibody therapy update
Published 2021Get full text
Series
Electronic Audio -
2
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Published 2020Get full text
Series
Electronic Audio -
3
Convalescent plasma therapy as a treatment for COVID-19
Published 2020Get full text
Series
Electronic Audio -
4
INFbeta therapy for COVID-19 the new SNG001 drug /
Published 2020Get full text
Series
Electronic Audio -
5
-
6
Development of PRO-140 (Leronlimab) as a treatment for COVID-19
Published 2020Get full text
Series
Electronic Audio -
7
Development of PRO-140 (Leronlimab) as a treatment for COVID-19
Published 2020Get full text
Series
Electronic Audio -
8
-
9
INFbeta therapy for COVID-19 the new SNG001 drug /
Published 2020Get full text
Series
Electronic Audio -
10
Convalescent plasma therapy as a treatment for COVID-19
Published 2020Get full text
Series
Electronic Audio -
11
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Published 2020Get full text
Series
Electronic Audio -
12
SARS-COV-2 human monoclonal antibody therapy update
Published 2021Get full text
Series
Electronic Audio